标题 |
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
对比细胞毒性和调节性T细胞应答,这是癌症中抗PD-1联合乐伐替尼治疗不同临床结局的基础
|
网址 | |
DOI | |
求助人 | |
下载 | 求助已完成,仅限求助人下载。 |